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SUMMARY : Surgical resection is the most useful modality of treatment for patients 
with lung cancer. However, two third of the patients who underwent pulmonary resection 
died within 5 years after operation due to recurrent diseases. This study reviewed 
long-term survivors (more than 10 years after lung resection) and examined the factors 
relating to prognosis and the quality of life of the patients after 10 years. 
 Two-hundred and forty-nine patients underwent pulmonary resections for bronchogenic 
carcinoma in the First Department of Surgery of Nagasaki University Hospital between 
1955 -and 1978. Among 237 who tolarated operations, 32 patients (13.5%) survived more 
than 10 years after pulmonary resections. There were 23 men and 9 women. Among 
the patients with stage I, 25/85 (29.4%) survived more than 10 years, while in the cases 
with Stage III, only 3/122 (2%) survived. There was no difference with survival rate bet-
ween the patients with squamous cell carcinoma and those with adenocarnoma. Thirty 
patients underwent lobectomy and only two with pneumonectomy survived more than 
10 years after surgery. Among 32 patients, 21 are alive and well without recurnce, 3 died 
of secondary primary lung cancer, one died of recurrent disease, and one died of gastic 
cancer. Most of the patients were free of respiratory symptoms after 10 years. 
 The favorable factors contribuitng to long-term survival after pulmonary resection for 
the patients with lung cancer are small and early lesions (Stage I, T1, N0, N1 ), lobectomy, 
cell types of squamous cell carcinoma or adenocarcinoma, and ages under 70 years. 
However, secondary lung tumors would occur to the patients who survived more than 
10 years after pulmonary resection, thus requiring continuous follow-up.
       INTRODUCTION 
 The prognostic factors of the patients after 
surgery for lung cancer would be the size of 
tumor, the extent of lymph node involvement 
or cell type') 2) 3). For the long-term survival, 
however, no lymph node metastasis, small tumor 
size or non-small cell carcinoma are related. 
Improved accuaracy of staging system, perio-
perative management of the patients and 
understanding and complete mediastinal node 
dissection, contributed to the good results of 
surgery of the lung cancer patients. There were 
several reports dealt with the patients survived 
more than 10 years after surgery4)s>s»)s)s)1o). In 
our study, we examined the factors relating to 
long term survival after operations and the 
quality of life of those after 10 years and 
discussed some problems associated with
long-term survival.
   MATERIALS AND METHODS 
 During the periods from 1955 through Decem-
ber 1978, two hundreds and forty-nine patients 
underwent lung resection for bronchogenic 
carinoma in the First Department of Surgery, 
Nagasaki University Hospital. Twelve patients 
(4.8%) died within 30 days after operation and 
were excluded from this study. The operative 
procedures performed were segmentectomy in 
2 patients, lobectomy in 165 (70%), bilobectomy 
in 34 and pneumonectomy in 36 (15%) (Table 1). 
Thirty-two patients survived more than 10 years 
after lung resection.
Table 1. Pulmonary resection for bronchogenic 
        carcinoma (1955-1978) 
  Operative No. of Operative No. of patients 
  procedure patients death involved 
Segmentectomy 2 0 2 
Lobectomy 170 5 165 
Bilobectmy 35 1 34 
Pneumonectomy 42 6 36 
   Total 249 12 237
          RESULTS 
 Of the 10-yeras survivors, 23 were men and 
9 were momen. The ages ranged from 39 to 
67 years. The 10-years survival rate. of male
patients was 13% and that of female was 15%. 
The 10 year survival rate of the patients under 
40 years of age were 14%, those between 40 and 
49, 17%, those between 50 and 59, 15% and those 
between 60 and 69, 13%. The patients over 70 
years of age did not survive more than 10 years 
after operation (Table 2). 
 Thirteen cases were classified histologically 
as squamous cell carcinoma and 13 were 
classified as adenocaricnoma, 4, large cell 
carcinoma and 2, others. The 10-year survival 
rated of the patients with squamous cell carci-
noma was 15%, those with adenocarcinoma, 13% 
those with large cell carcinoma, 15%. There were 
no patients with small cell caricnoma survived 
more than 10 years (Table 3). 
 The 10-year survival rate of the patients with 
Stage I was 30%, those with Stage II, 14% and 
those with Stage III, only 2.5% respectively. 
 The 10-year survival rates of the patients who 
did not have lymphatic spread were 25% (26% 
in squamous cell carcinoma, 24% in adeno-
carcinoma and 27% in large cell carcinoma). 
Those of the patients with hilar node 
involvement were 16% and those of medi-
astinal node metastasis, only 2% (Table 4). 
 The 10-year survival rate of the patients with 
lobecectomy was 17%, while those with bilo-
bectomy, 6% and those with pneumonectomy, 
6%. None of 2 patients who underwent pneumo-
nectomy died with recurrent lung cancer (Table 
5). 
 Twenty-eight of 32 patients underwent cura-
                Table 2. Ten-year survivors : Age and sex (%) 
Age (years) -39 40-49 50^-59 60^-69 70- Total 
  Male 1/2(50.0) 6/35(17.1) 9/59(15.2) 7/65(10.8) 0/16 23/177 (13.0) 
 Female 0/5 2/13(15.4) 2/16(12.5) 5/25(20.0) 0/ 1 9/ 60 (15.0) 
 Total 1/7(14.3) 8/48(16.7) 11/75 (14.7) 12/90 (13.3) 0/17 32/237 (13.5)
             Table 3. Ten-year survivors : Cell type and stage (%) 
   Cell type stage I stage II stage III stage IV Total 
Squamous cell ca. 9/33(27.3) 1/ 9(11.1) 2/ 41(4.9) 1/3(33.3) 13/ 86 (15.1) 
Adenocarcinoma 11/38 (28.9) 1/ 7(14.3)- 1/ 52(1.9) 0/5( 0) 13/102 (12.7) 
Large cell ca. 3/ 9(33.3) 1/ 3(33.3) 0/ 14( 0) 0/1( 0) 4/ 27 (14.8) 
Small cell ca. 0/ 1( 0) 0/ 2 ( 0) 0/ 7 ( 0) 0/ 10( 0) 
Others 2/ 4(50.0) 0/ 8 ( 0) 2/ 12 (16.7) 
    Total 25/85 (29.4) 3/21(14.3) 3/122(2.5) 1/9(11.1) 32/237 (13.5)
     Table 4. Ten-year survivors : Lymph node invovement and cell type (%) 
    Cell type N„ N, N2 N:; Total 
Squamous cell ca. 10/39 (25.6) 2/15(13.3) 1/29(3.4) 0/ 3 ( 0) 13/ 86 (15.1) 
Adenocarcinoma 10/42 (23.8) 2/14(14.3) 1/41(2.4) 0/ 5 ( 0) 13/102 (12.7) 
Large cell ca. 3/11(27.3) 1/ 6(16.7) 0/14( 0) 0/ 1 ( 0) 4/ 27 (14.8) 
Small cell ca. 0/ 1 ( 0) 0/ 3 ( 0) 0/ 7 ( 0) 0/ 10( 0) 
Others 2/ 7(28.6) 0/ 8 ( 0) 0/ 1 ( 0) 2/ 12 (16.7) 
    Total 25100 (25.0) 5/38(13.2) 2/89(2.2) 0/10( 0) 32/237 (13.5)
        Table 5. Ten-year survivors : Operative procedure and curability (%) 
   Procedure Curative Relative curative Non-curative Total 
Segmentectomy 0/ 2 ( 0) 0/ 2 ( 0) 
Lobectomy 24/ 81 (29.6) 3/54(5.6) 1/30( 0) 28/165 (17.0) 
Bilobectomy 2/ 10 (20.0) 0/14( 0) 0/10( 0) 2/ 34( 5.9) 
Pneumonectomy 2/ 10(20.0) 0/15( 0) 0/11( 0) 2/ 36( 5.6) 
Total 28/101(27.7) 3/85(3.5) 1/51(2.0) 32/237 (13.5)
          Table 6. Ten-year survivors : Causes of death 
   Prognosis No. of patients Cause of death 
alive cancer (-) 21 
      cancer (+) 0
      cancer (+) 5 lung cancer (primary) 3 
dead lung cancer (metastatic) 1 
                                  gastric cancer 1 
       cancer (-) 6 cerebral embolism 1
                              cerebral bleeding 1
                               Esophageal varix 1
                               renal failure 1
                                  unknown 2
Live operations. However, only 4% of the patients 
with relative curative operations survived more 
than 10 years. One of the 51 patients with 
non-curative operation, who had ipsilateral 
solitary lung metastasis at thoracotomy, 
survived 17 years after left lower lobectomy. 
 Eleven patients died between 11 and 19 years 
after operation. The causes of death were lung 
cancer in 4 patients, gastric cancer in one, 
cerebral diseases in 2, rupture of esophageal 
varix in one, renal failure in one and unknown 
in two. 
 Twenty-one of the 32 10 year survivors are 
alive from 10 years through 20 after operation 
at this writing. At present, the ages range from 
52 years old and 82. They are free of recu-
rrence of lung cancer and spend daily life 
without difficulty.
Table 7. Prognosis of the patients survied more 
        than 10 years after lung resection for 
        bronchogenic carcinoma. 
 Surival (yr) No. of patients Still alive Dead 
   10-14 23 15 8 
   15-19 8 5 3
   20- 1 1 0
         DISCUSSION 
 Primary lung cancer is considered as one of 
the malignant tumors with the poor prognaosis 
and cured only by surgical treatment. With 
regards to increasing numbers of resected cases 
with lung cancer, several reports have appeared 
concerning about long-term survivors more than 
10 years. In the literatures, 10-year survival rates
were 18% in Watson'), 18% in Ashor6), 12% in 
Shields'' and 20% in SOrensen10>. There were 
no differences among those reports about 
10-year survival rates. Our 10-year survival rate 
of the resected cases for lung cancer was 14%, 
almost the same to the previous reports. 
 There were many reports which mentioned 
about various factors relating to the prognosis 
after lung resection for bronchogenic carinoma. 
However, different results were reported 
because of differenct materials. The most 
important factor related to survival is the extent 
of regional lymph nodes metastasis. The 
patients with no hilar or mediastinal lymph 
node metastasis usually survive longer. 
Contrarily the patients with mediastinal lymph 
node involvement have grave prognosis. 
 In our patients, 10-year survival rates of the 
cases without lymph node metastasis were 25%, 
but, those with mediatinal lymph node metas-
tasis were only 2.2%. There were statistically 
significant difference between them. 
 There were some controversies whether the 
histologic type of lung cancer influences the 
prognosis after surgery. It is clear that the 
patients with small cell carcinoma have poor 
prognosis. Higgins", Kirsh 11 >, and Stevenson'"> 
reported that postoperative survival rate of the 
patients with squamous cell carcinoma is better 
than those of sdenocarcinoma or large cell caci-
noma. On the other hand, Shields2>, Paulson') 
and Vincent') described that there were no 
difference of postoperative survival rates among 
cell types. However, Shields2> presented that in 
the cases with mediastinal lymph node metas-
tasis, the survival rate of the patients with 
squamous cell carcinoma was better than those 
with other cell types. We observed that there 
were no difference in survival among cell types 
except for small cell carcinoma. 
 With regard to the influence of tumor size to 
prognosis, Yashar2' and Tarkka13) stated that 
the smaller the size was, the better the prognosis 
was (those cases with less than 2cm had 61% 
of 5-year survival rate, whereas those with more 
than 4.5cm had only 4.3%). However, Shields2> 
reported that the size of the tumor ded not 
influence the survival rate of the patients after 
evaluating multi-factor analysis. 
 Then, how about the operative porcedures?
Yasher3>, Brock'), Shields9>, and Sgrensenz0> 
reported that there were no differences in 
survival after surgery between lobectomy and 
pneumonectomy. However, there were several 
reports that the survival rates with lobectomy 
were better than those of pneumonectomy. 
Ten-year survival rates of the patients with 
lobectomy and pneumonectomy were 20% and 8% 
in Vincent's report'), 22% and 8% in Paulson's7> 
and 28% and 12.8% in Ashors'6>. Kirsh reported 
that in the squamous cell carcinoma, lobectomy 
had better 10-year survival rate than pneumo-
nectomy and in the patient with adeno-
carinoma or undifferentiated cariconoma, there 
were no long-term survivors of pneumonectomy 
patients. He stated that operative indication 
should be strictly evaluated. 
 In our cases, the patients with lobectomy had 
better prognosis than those with pneumo-
nectomy. However, our cases with pneumo-
nectomy had often central and mediastinal node 
metastasis. 
 The other factors contributing to prognosis 
were reported as age, associated pulmonary 
diseases such as chronic emphysema, location 
of tumor and positive margin of resescted 
bronchus. 
 The quality of life of the patients who 
survived more than 10 years after operation was 
relatively well. They have spent almost normal 
daily life without difficulty and no respiratory 
symptoms. The reason why our patients had 
little respiratory porbiem is that they underwent 
lobectomy. In the literatures, the patients with 
pneumonectomy had handicap compared with 
those with lobectomy 10 years after surgery. 
Watson') and Valente15> reported that the 
patients with pneumonectomy had more or less 
pulmonary hypertension due to overinflation of 
the residual opposite lung and had a tendency 
of later death. 
 One of the problems when the patients 
survived more than 10 years after lung resection 
is the relatively high frequency of secondary 
cancers". Not only the secondary lung cancer 
but also cancers in other organs such as gastric 
cancer may occur in the patients. Therefore, 
long-term follow up is necessary to detect such 
secondary cancers. 
 In conclusion, long-term survival can be
achieved in the patients who underwent lung 
resection for bronchogenic carcinoma. The 
favorite factors contibuting to long-term 
survival of the patients with lung cancer are 
small and early lesions (Stage I, T1, NO or N1), 
ages under 70 year, lobectomy with curative 
oparation, cell types with non-small cell carci-
noma. However, secondary lung tumors might 
occur in the patients survived more than 10 
years after pulmonary resection. Therefore 
continuous follow-up is necessary.
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